Literature DB >> 1728160

Verapamil versus lithium in acute mania.

E S Garza-Treviño1, J E Overall, L E Hollister.   

Abstract

Twenty acutely manic patients were studied in a double-blind randomized trial comparing verapamil with lithium. The Petterson Mania Scale, the Brief Psychiatric Rating Scale (BPRS), and the Clinical Global Impression (CGI) were administered before treatment and weekly during 4 weeks of treatment to evaluate response to verapamil and lithium. Both treatment groups improved significantly, and there were no significant overall differences between treatments.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1728160     DOI： 10.1176/ajp.149.1.121

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  10 in total

1.  Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.

Authors:  Michele L Ulrich; Susan Rotzinger; Sheila J Asghar; Paul Jurasz; Veronique A Tanay; Susan M J Dunn; Marek Radomski; Andy Greenshaw; Peter H Silverstone
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

Review 2.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

3.  Diltiazem as augmentation therapy in patients with treatment-resistant bipolar disorder: a retrospective study.

Authors:  P H Silverstone; L Birkett
Journal:  J Psychiatry Neurosci       Date:  2000-05       Impact factor: 6.186

4.  Comparative study of electrocardiographic changes in patients of acute mania receiving verapamil or lithium carbonate.

Authors:  Mukhtiar Singh; Sharanjit Kaur; Vijay Kumar Sehgal
Journal:  J Clin Diagn Res       Date:  2014-12-05

Review 5.  Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.

Authors:  Jorge M Tamayo; Carlos A Zarate; Eduard Vieta; Gustavo Vázquez; Mauricio Tohen
Journal:  Int J Neuropsychopharmacol       Date:  2010-02-04       Impact factor: 5.176

Review 6.  Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?

Authors:  Beth Sproule
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 7.  Treatment approaches for acute mania.

Authors:  J C Chou; I Tuma; E A Sweeney
Journal:  Psychiatr Q       Date:  1993

Review 8.  Neuropsychiatric consequences of cardiovascular medications.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

9.  Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions.

Authors:  Claudia Pisanu; Donatella Congiu; Giovanni Severino; Raffaella Ardau; Caterina Chillotti; Maria Del Zompo; Bernhard T Baune; Alessio Squassina
Journal:  Neuropsychopharmacology       Date:  2021-05-25       Impact factor: 8.294

Review 10.  A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

Authors:  A Cipriani; K Saunders; M-J Attenburrow; J Stefaniak; P Panchal; S Stockton; T A Lane; E M Tunbridge; J R Geddes; P J Harrison
Journal:  Mol Psychiatry       Date:  2016-05-31       Impact factor: 15.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.